The Gift of Participation: A Guide to Making Informed Decisions about Volunteering for a Clinical TrialCISCRP, 2007 - 360 sider Kennth Getz takes a fresh look at why participation in clinical research really matters. This book addresses what clinical participation means and how it helps to advance medical science. Practical information on subjects like insurance coverage, compensation, and tax ramifications for clinical research volunteers also is included. With a foreword written by Congressman Rick Boucher of Virginia, and a back cover endorsement from Tour de France winner and cancer survivor Lance Armstrong, offers a road map into a world many readers are just beginning to explore. |
Inni boken
Resultat 1-5 av 83
Side vi
... Human Subject Protection 197 CHAPTER ELEVEN Considerations for Special Populations 219 CHAPTER TWELVE What to Do When Things Go Wrong 237 AFTERWORD 239 APPENDIX ... Subjects 309 APPENDIX F 21 CFR 50 - Protection of Human vi Table of Contents.
... Human Subject Protection 197 CHAPTER ELEVEN Considerations for Special Populations 219 CHAPTER TWELVE What to Do When Things Go Wrong 237 AFTERWORD 239 APPENDIX ... Subjects 309 APPENDIX F 21 CFR 50 - Protection of Human vi Table of Contents.
Side vii
... Human Subjects 323 APPENDIX G Form 1572 325 APPENDIX H Directory of Health Associations 331 APPENDIX I Directory of Pharmaceutical and Biotechnology Companies 360 ABOUT THE AUTHOR FOREWORD Recently, I introduced a resolution in the ...
... Human Subjects 323 APPENDIX G Form 1572 325 APPENDIX H Directory of Health Associations 331 APPENDIX I Directory of Pharmaceutical and Biotechnology Companies 360 ABOUT THE AUTHOR FOREWORD Recently, I introduced a resolution in the ...
Side xiii
Beklager, innholdet på denne siden er tilgangsbegrenset..
Beklager, innholdet på denne siden er tilgangsbegrenset..
Side 50
Beklager, innholdet på denne siden er tilgangsbegrenset..
Beklager, innholdet på denne siden er tilgangsbegrenset..
Side 51
Beklager, innholdet på denne siden er tilgangsbegrenset..
Beklager, innholdet på denne siden er tilgangsbegrenset..
Innhold
CHAPTER | 1 |
CHAPTER | 17 |
CHAPTER THREE | 31 |
CHAPTER FOUR | 49 |
CHAPTER FIVE | 73 |
CHAPTER | 97 |
CHAPTER SEVEN | 119 |
CHAPTER EIGHT | 153 |
CHAPTER ELEVEN | 197 |
CHAPTER TWELVE | 219 |
AFTERWORD | 237 |
of Helsinki | 263 |
APPENDIX | 285 |
APPENDIX | 309 |
APPENDIX | 323 |
ABOUT THE AUTHOR | 360 |
Vanlige uttrykk og setninger
adverse events agency head Alzheimer’s disease applicable assent Association Belmont Report benefit Blvd cancer cholesterol clinical investigation clinical research clinical trial conducted consent form Declaration of Helsinki department or agency diabetes doctors dose enrolled ensure ethical federal fetus Framingham Heart Study Gleevec Health and Human heart disease ical individual informed consent institutional review board investigational drug investigational new drug involving human subjects jects Lipitor medicine ment minimal risk monitoring neonate Nuremberg Code OHRP patients pediatric person pharmaceutical companies phase physician placebo potential Pregabalin pregnant women principal investigator prisoners procedures receive regulations research centers research involving human research subjects responsible safety side effects specific sponsor study coordinator study drug study participants study protocol study staff study volunteers subpart Suite therapeutic therapy tion treat treatment visits